Hiro Capital Celebrates Award of Knighthood to Co-Founding Partner, Sir Ian Livingstone, in Recognition of His Service to Video Games
3.1.2022 17:15:00 EET | Business Wire | Press release
Today, Hiro Capital is proud to announce that its co-founding Partner, Ian Livingstone has been granted the title of Knight Bachelor by HRH Queen Elizabeth II. Sir Ian is best known as one of the founders of Games Workshop (Warhammer) and Eidos (Lara Croft Tomb Raider) and as the creator of the Fighting Fantasy series of adventure game novels. Over the course of his legendary career, Sir Ian has made innumerable contributions to the art and industry of video and role-playing games. Three of Ian’s recent investments - Tonic Games (Fall Guys), Playdemic (Golfclash), and Sumo Digital - were acquired in 2021 at unicorn valuations and Hiro Capital has made 20 early-stage games investments in the last 2 years.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220103005197/en/
Sir Ian Livingstone (Photo: Business Wire)
“With 5 unicorn scale games start-ups under his knightly belt, Hiro Capital is proud to celebrate Sir Ian’s knighthood. His bravery, chivalry, courtliness, and hermetical talents make him one of the most powerful paladins in video games. We are proud to have Sir Ian co-leading the Hiro Capital guild of mages and sell-swords as we ride forward into the Metaverse of 2022,” said Luke Alvarez and Cherry Freeman, Hiro co-founders.
“Simply put, it is a huge honor for me and great recognition for the UK games industry. The industry has come a long way since I founded my first startup and I believe more than ever in Games and Gameplay as a global force for good.” - said Sir Ian Livingstone.
Ian also recently founded the Livingstone Academy, which opened its doors in September - an all-through school for ages four to eighteen that aims to give its students the tools they need to succeed as young creators in a digital world. Find out more - https://www.livingstone-aspirations.org/
Hiro Capital: Investors in the Future
Hiro Capital is a London / Luxembourg technology Venture Capital fund which invests in UK, US, and European innovators in Games, IP, Metaverse Technology, Web 3.0, Esports, and Gamified Fitness. Hiro Capital generally invests at Seed through Series A and B stages. We invest both in front-end Content creators in Games, IP, Esports, and Digital Fitness and in deep tech Metaverse and Web 3.0 applications of Cloud, Mobile, Streaming, Creator Tools, Big Data, AI, Wearables, AR, and VR. - https://hiro.capital/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220103005197/en/
Contact information
PR Contact
Bill Murphy
Bill@TeamCriticalHit.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 15:00:00 EET | Press release
Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end workflows spanning onboarding, KYC, AML, fraud, underwriting, payments, disputes, servicing, and collections. For
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom